Skip to content

Application of ultrasonic-guided transverse thoracic muscle block in endoscopic thymoma resection

Application of ultrasonic-guided transverse thoracic muscle block in endoscopic thymoma resection

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061228
Enrollment
Unknown
Registered
2022-06-16
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thymoma

Interventions

Group 1 :Bilateral transverse thoracic muscle combined with bilateral rectus sheath plane block
Group 2:No nerve block

Sponsors

The First Affiliated Hospital of Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 18-65 years old; 2. ASA I-II; 3. Thymoma resection.

Exclusion criteria

Exclusion criteria: 1. Patients who have contraindications of transverse thoracic muscle block (allergic to anesthetics used in this study, serious abnormal coagulation function, obvious abnormal platelet count, infection at puncture site, etc.) or refuse to receive nerve block, morbid obesity (BMI > 40 kg/m2) and high-risk patients with malignant hyperthermia; 2. People with a history of mental and neurological diseases, alcohol and drug abuse, and long-term use of opioids or stable drugs; 3. Preoperative radiotherapy and chemotherapy, preoperative chronic pain, preoperative chronic pain, neuromuscular disease, pregnancy; 4. Patients who are unable to cooperate with this study due to certain reasons (such as deafness, blindness, language communication barriers, etc.); 5. Patients lost to follow-up.

Design outcomes

Primary

MeasureTime frame
QoR-15 scale score;Additional postoperative analgesic drug dosage;

Secondary

MeasureTime frame
Patient satisfaction;Incidence of postoperative complications;

Countries

China

Contacts

Public ContactShun Wang

The First Affiliated Hospital of Chengdu Medical College

635245417@qq.com+86 18148040132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026